The studies described in this report find that acute gene silencing and chemical inhibition of GSK-3 increase basal NFκB activity in PCa, and that combined inhibition of GSK-3 and NFκB signaling is more effective than inhibition of each alone for reducing PCa cell proliferation. This evidence concerns the gene NFKB1 and posterior cortical atrophy.